ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

GENE Genetic Technologies Ltd

2.8899
0.0799 (2.84%)
Mar 28 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Genetic Technologies Ltd GENE NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
0.0799 2.84% 2.8899 19:11:17
Open Price Low Price High Price Close Price Prev Close
2.80 2.80 2.94 2.89 2.81
more quote information »

Recent News

Date Time Source Heading
3/26/202408:00GLOBEGTG Global Collaborations and Innovation Update
3/25/202408:00GLOBEGENE to develop Worlds Most Advanced Comprehensive Risk Test..
2/26/202408:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/15/202408:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/14/202414:14EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/31/202408:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/31/202408:00GLOBELaunching our most comprehensive test and expanding into new..
1/09/202408:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/05/202408:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/05/202408:00GLOBEGenetic Technologies Regains Compliance with Nasdaq Minimum..
1/05/202400:15EDGAR2Form EFFECT - Notice of Effectiveness
12/28/202308:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/27/202308:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/20/202317:00EDGAR2Form F-3 - Registration statement by foreign private issuers
12/14/202308:00GLOBEGeneType's Groundbreaking Saliva Test Transforms Early..
12/12/202308:00GLOBEGenetic Technologies Limited Announces Ordinary Share..
10/30/202308:00GLOBEGene Business Update: Private Hospital Partnership; Expanded..
10/18/202308:30GLOBEGeneType Predicting Risk of Pancreatic Cancer: Major..
9/27/202309:00GLOBEGTG Signs Precision Medicine Pilot with Australia’s Largest..
9/12/202308:00GLOBEBreakthrough: GeneType for Pancreatic Cancer, Melanoma, and..
9/11/202308:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/11/202308:30GLOBEGENE Positioned at the Forefront of Multi-cancer Clinical..
9/11/202308:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/01/202310:00GLOBEGenetic Technologies Limited and 60 Degrees Pharmaceuticals..
8/30/202308:45GLOBEAnnual Results – Momentum Building on our Commercial Plans
8/09/202308:00GLOBEGenetic Technologies Limited Announces Updated Investor..
7/28/202308:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/28/202308:00GLOBEQuarterly Activities Update: Encouraging Growth for geneType..
7/21/202308:00GLOBEGenetic Technologies Receives Nasdaq Notification Regarding..
5/23/202308:00GLOBEGeneType featured on U.S. National TV to raise Breast Cancer..
4/28/202308:00GLOBENew Publication Validates geneType for Melanoma Risk..
4/27/202308:00GLOBEQuarterly Business Update – March 2023
4/19/202308:00GLOBEPublication Validates geneType Prostate Cancer Risk Test

Your Recent History

Delayed Upgrade Clock